These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 1667490

  • 1. [Expression, amplification and rearrangement of c-myc gene in human thyroid carcinoma].
    Yang Y.
    Zhonghua Yi Xue Za Zhi; 1991 Jun; 71(6):304-6, 22. PubMed ID: 1667490
    [Abstract] [Full Text] [Related]

  • 2. Overexpression of c-myc gene without gene amplification in human hepatocellular carcinoma.
    Wu B, Wang M, You W, Yang S.
    Chin Med J (Engl); 1996 Dec; 109(12):922-5. PubMed ID: 9275322
    [Abstract] [Full Text] [Related]

  • 3. C-myc, N-myc, N-ras, and c-erb-B: lack of amplification or rearrangement in human medullary thyroid carcinoma and a derivative cell line.
    Yang KP, Castillo SG, Nguyen CV, Hickey RC, Samaan NA.
    Anticancer Res; 1990 Dec; 10(1):189-92. PubMed ID: 2185686
    [Abstract] [Full Text] [Related]

  • 4. Overexpression and amplification of c-myc and c-Ha-ras oncogenes in pleomorphic salivary adenoma.
    Xue H, Situ ZQ, Wang CJ, Wu JZ.
    Chin Med J (Engl); 1993 Jan; 106(1):22-5. PubMed ID: 8389270
    [Abstract] [Full Text] [Related]

  • 5. Genome-wide expression analysis of Middle Eastern papillary thyroid cancer reveals c-MET as a novel target for cancer therapy.
    Siraj AK, Bavi P, Abubaker J, Jehan Z, Sultana M, Al-Dayel F, Al-Nuaim A, Alzahrani A, Ahmed M, Al-Sanea O, Uddin S, Al-Kuraya KS.
    J Pathol; 2007 Oct; 213(2):190-9. PubMed ID: 17703498
    [Abstract] [Full Text] [Related]

  • 6. Protein expression and molecular analysis of c-myc gene in primary breast carcinomas using immunohistochemistry and differential polymerase chain reaction.
    Naidu R, Wahab NA, Yadav M, Kutty MK.
    Int J Mol Med; 2002 Feb; 9(2):189-96. PubMed ID: 11786932
    [Abstract] [Full Text] [Related]

  • 7. [Expression of protooncogene bcl-2 in thyroid tumors].
    Zhu J, Chen Y, Xue H.
    Zhonghua Yi Xue Za Zhi; 1996 Nov; 76(11):829-31. PubMed ID: 9275533
    [Abstract] [Full Text] [Related]

  • 8. Is the presence of distant metastasis associated with c-myc amplification in gastric cancer?
    Hajdú J, Kozma L, Kiss I, Szentkereszty Z, Szakáll S, Ember I.
    Acta Chir Hung; 1997 Nov; 36(1-4):119-21. PubMed ID: 9408311
    [Abstract] [Full Text] [Related]

  • 9. Overexpression of either c-myc or c-erbB-2/neu proto-oncogenes in human breast carcinomas: correlation with poor prognosis.
    Guérin M, Barrois M, Terrier MJ, Spielmann M, Riou G.
    Oncogene Res; 1988 Nov; 3(1):21-31. PubMed ID: 2905033
    [Abstract] [Full Text] [Related]

  • 10. Low-level c-myc amplification in human colonic carcinoma cell lines and tumors: a frequent, p53-independent mutation associated with improved outcome in a randomized multi-institutional trial.
    Augenlicht LH, Wadler S, Corner G, Richards C, Ryan L, Multani AS, Pathak S, Benson A, Haller D, Heerdt BG.
    Cancer Res; 1997 May 01; 57(9):1769-75. PubMed ID: 9135021
    [Abstract] [Full Text] [Related]

  • 11. Oncogenes and growth factors in thyroid carcinogenesis.
    Frauman AG, Moses AC.
    Endocrinol Metab Clin North Am; 1990 Sep 01; 19(3):479-93. PubMed ID: 2175702
    [Abstract] [Full Text] [Related]

  • 12. Block of c-myc expression by antisense oligonucleotides inhibits proliferation of human thyroid carcinoma cell lines.
    Cerutti J, Trapasso F, Battaglia C, Zhang L, Martelli ML, Visconti R, Berlingieri MT, Fagin JA, Santoro M, Fusco A.
    Clin Cancer Res; 1996 Jan 01; 2(1):119-26. PubMed ID: 9816098
    [Abstract] [Full Text] [Related]

  • 13. Reduced expression of N-Myc downstream-regulated gene 2 in human thyroid cancer.
    Zhao H, Zhang J, Lu J, He X, Chen C, Li X, Gong L, Bao G, Fu Q, Chen S, Lin W, Shi H, Ma J, Liu X, Ma Q, Yao L.
    BMC Cancer; 2008 Oct 22; 8():303. PubMed ID: 18940011
    [Abstract] [Full Text] [Related]

  • 14. [Molecular biological study on the overexpression of c-myc gene in uterine cervical carcinomas].
    Tanimoto H, Nagai N, Fujimoto H, Ohta S, Ohama K.
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 May 22; 44(5):566-70. PubMed ID: 1619315
    [Abstract] [Full Text] [Related]

  • 15. Gene expression profiling of differentiated thyroid neoplasms: diagnostic and clinical implications.
    Chevillard S, Ugolin N, Vielh P, Ory K, Levalois C, Elliott D, Clayman GL, El-Naggar AK.
    Clin Cancer Res; 2004 Oct 01; 10(19):6586-97. PubMed ID: 15475448
    [Abstract] [Full Text] [Related]

  • 16. Activation of c-MYC and c-MYB proto-oncogenes is associated with decreased apoptosis in tumor colon progression.
    Greco C, Alvino S, Buglioni S, Assisi D, Lapenta R, Grassi A, Stigliano V, Mottolese M, Casale V.
    Anticancer Res; 2001 Oct 01; 21(5):3185-92. PubMed ID: 11848471
    [Abstract] [Full Text] [Related]

  • 17. [Synergism of c-myc and p16 in oral squamous cell carcinoma].
    Liu NG, Shan CM, Wu SH, Lu ZH, Kang GY.
    Ai Zheng; 2004 Jun 01; 23(6):635-9. PubMed ID: 15191661
    [Abstract] [Full Text] [Related]

  • 18. Fish detected p53 deletion and N-MYC amplification in colorectal cancer.
    Ozakyol A, Ozdemir M, Artan S.
    Hepatogastroenterology; 2006 Jun 01; 53(68):192-5. PubMed ID: 16608022
    [Abstract] [Full Text] [Related]

  • 19. Neuroblastoma with DNA amplification and rearrangement in the N-myc gene region.
    Hiyama E, Hiyama K, Yokoyama T.
    Cancer Res; 1991 Apr 01; 51(7):1946-51. PubMed ID: 2004381
    [Abstract] [Full Text] [Related]

  • 20. c-Met expression in tall cell variant papillary carcinoma of the thyroid.
    Nardone HC, Ziober AF, LiVolsi VA, Mandel SJ, Baloch ZW, Weber RS, Mick R, Ziober BL.
    Cancer; 2003 Oct 01; 98(7):1386-93. PubMed ID: 14508824
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.